<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03410511</url>
  </required_header>
  <id_info>
    <org_study_id>P2016/466 / B406201629930</org_study_id>
    <nct_id>NCT03410511</nct_id>
  </id_info>
  <brief_title>Propylene Glycol/Glycerol Intake and Cardiorespiratory Function</brief_title>
  <acronym>PGGICF</acronym>
  <official_title>Reversibility of Propylene Glycol/Glycerol Intake Effects on Cardiorespiratory Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université Libre de Bruxelles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université Libre de Bruxelles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propylene glycol/Glycerol intake is increasingly popular. The propylene glycol/glycerol
      intake effects on cardiorespiratory function are unknown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background. Propylene glycol/Glycerol intake is increasingly popular. The propylene
      glycol/glycerol intake effects on cardiorespiratory function are unknown. Weaning of
      propylene glycol/glycerol could allows a quick clearance of propylene glycol/glycerol from
      the body, with subsequent recovery of cardiorespiratory function.

      Specific aim of the research. This research proposal tests the following hypothesis regarding
      the reversibility of propylene glycol/glycerol and nicotine intake:

        -  Propylene glycol/glycerol cessation restores cardiorespiratory function.

        -  Chronic propylene glycol/glycerol and propylene glycol/glycerol/nicotine intake induces
           specific serum and urine proteomics profile, which are partially reversed after
           cessation.

        -  Chronic propylene glycol/glycerol and propylene glycol/glycerol/nicotine intake induces
           specific serum and urine metabolomics profile, which are partially reversed after
           cessation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cardiorespiratory function</measure>
    <time_frame>4 hours</time_frame>
    <description>Continuous monitoring of cardiorespiratory function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum and urine proteomics profiles</measure>
    <time_frame>1 hour</time_frame>
    <description>Serum and urine proteomics</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in serum and exhaled breath condensate metabolomics profiles</measure>
    <time_frame>1 hour</time_frame>
    <description>Serum and exhaled breath condensate metabolomics</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Lung Injury</condition>
  <arm_group>
    <arm_group_label>Nicotine free intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participant will wean off nicotine during five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participant will pursuit his regular nicotinic propylene/glycerol intake five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol/nicotine (mix 50:50) intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cessation intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participant will completely stop his regular nicotinic propylene/glycerol intake during five days before the session. At the start of the experimental session, participants will mimick intake with the device turns off.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nicotine free intake</intervention_name>
    <description>The participant will wean off nicotine during five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.</description>
    <arm_group_label>Nicotine free intake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nicotine intake</intervention_name>
    <description>The participant will pursuit his regular nicotinic propylene/glycerol intake five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.</description>
    <arm_group_label>Nicotine intake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cessation intake</intervention_name>
    <description>The participant will completely stop his regular nicotinic propylene/glycerol intake during five days before the session. At the start of the experimental session, participants will mimick intake with the device turns off.</description>
    <arm_group_label>Cessation intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be regular propylene glycol/glycerol/nicotine intake users since at least
             1 year

          -  Subject must be former smokers

        Exclusion Criteria:

          -  Chronic or acute illness

          -  Substance abuse

          -  Chronic medication intake
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe van de Borne, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Université Libre de Bruxelles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe van De Borne, MD, PhD</last_name>
    <phone>+32 (0)2 555 56 64</phone>
    <email>Philippe.Van.de.Borne@erasme.ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin Chaumont, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <state>Anderlecht</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2018</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2018</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université Libre de Bruxelles</investigator_affiliation>
    <investigator_full_name>Martin Chaumont</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

